Kidney stone formation and antioxidant effects of Cynodon dactylon decoction in male Wistar rats

سال انتشار: 1396
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 392

فایل این مقاله در 11 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_AJP-7-2_010

تاریخ نمایه سازی: 18 تیر 1398

چکیده مقاله:

Objectives: The antioxidant capacity impairs in kidney and urinary bladder of animals with stone disease. Herbal medicine can improve the antioxidant condition of renal tissue. Cynodon dactylon (C. dactylon) is a medicinal plant with antioxidative and diuretic properties and different preparations of this plant have shown promising effects in stone disease. Assessment of the whole plant decoction to prevent kidney stone disease as well as its antioxidant effects was the aim of this paper.Materials and Methods: Fifty male Wistar rats were randomly divided into 5 experimental groups (n=10). One group was left without treatment and four groups received ethylene glycol (1% v/v) in drinking water for 6 weeks. Three doses of Cynodon dactylon aqueous decoction (12.5, 50 and 200 mg/kg BW) were added to the drinking water of groups 3-5. Finally, water intake, 24-hour urine volume, MDA, total thiol concentration and FRAP value were measured in the serum and kidney tissues. The CaOx depositions were evaluated by hematoxylin and eosin staining.Results: Compared to the ethylene glycol-treated group, 200 mg/kg C. dactylon, lowered stone incidents, decreased urine volume, increased FRAP/g Cr (43%) and thiol content (p<0.05) with no significant alteration of water intake, MDA decreased significantly compared to C. dactylon 12.5  (p<0.01). Kidney weight increased and body weight decreased in ethylene glycol-treated group compared to the control group (p<0.05). Conclusion: A minimum dose of 200 mg/kg C. dactylon reduced stone formation and simultaneously increased total antioxidant power of serum and preserved MDA content and water.

نویسندگان

Alireza Golshan

School of Medicine, North Khorasan University of Medical sciences, Bojnurd, Iran

Parichehr Hayatdavoudi

Neurocognitive Research Center, Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Mousa AL-Reza Hadjzadeh

Neurocognitive Research Center, Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Abolfazl Khajavi Rad

Neurogenic Inflammation Research Center,Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Alex M, Varghese MV, Abhilash M, Paul MVS. 2013. Effect ...
  • Arumugam N, Boobalan T, Rajeswari PR, Duraimurugan MD. 2014. Antimicrobial ...
  • Atmani F, Sadki C, Aziz M, Mimouni M, Hacht B. ...
  • Bihl G, Meyers A. 2001. Recurrent renal stone disease — ...
  • Devi KMS, Annapoorani S, Ashokkumar K. 2011. Hepatic antioxidative potential ...
  • Garjani A, Afrooziyan A, Nazemiyeh H, Najafi M, Kharazmkia A, ...
  • Giannerini F, Giustarini D, Lusini L, Rossi R, Simplicio P ...
  • Gupta R, Sharma M, Lakshmy R.2009. Improved method of total ...
  • Hadjzadeh M, Khajavi-rad A, Rajaei Z, Tehranipour M, Monavar N. ...
  • Hadjzadeh MA, Khoei A, Hadjzadeh Z. 2007. Ethanolic extract of ...
  • Halperin ML, Kamel KS, Oh MS. 2008. Mechanisms to concentrate ...
  • Harris RH, Yarger WE, Carolina N. 1975. The pathogenesis of ...
  • Hosseinzadeh H, Hosseini A, Nassiri-asl M, Sadeghnia HR. 2007. Effect ...
  • Hosseinzadeh H, Sadeghnia HR, Ziaee T, Danaee A. 2005. Protective ...
  • Huang H, Ma M, Chen J, Chen C. 2002. Changes ...
  • Itoh Y, Yasui T, Okada A, Tozawa K, Hayashi Y, ...
  • Khajavi- Rad A, Hajzadeh M, Rajaei Z, Sadeghian MH. 2011. ...
  • Khajavi-Rad A, Hadjzadeh M, Rajaei Z, Mohammadian N, Valiollahi S, ...
  • Khan SR. 2010. Nephrocalcinosis in animal models with and without ...
  • Khlifi D, Akrem E, Valentin A, Cazaux S, Moukarzel B, ...
  • Lim CSH, Lim SL. 2013. Ferric reducing capacity versus ferric ...
  • Ma M, Chen Y, Huang H. 2014. Erythrocyte oxidative stress ...
  • Mangathayaru K, Umadevi M, Reddy CU. 2009. Evaluation of the ...
  • Mckenzie G, Hall J. 2013. Management of stone disease. Surgery, ...
  • Miraldi E, Ferri S, Mostaghimi V. 2001. Botanical drugs and ...
  • Mohebbati R, Shafei MN, Soukhtanloo M, Karimi S, Beheshti F. ...
  • NouvenneA, Meschi T, Guerra A, Allegri F, Prati B, Borghi ...
  • Ramegowda D, Shekhar C, Browning AJ, Cartledge JJ. 2007. The ...
  • RomeroV, Akpinar H, Assimos DG. 2010. Kidney stones : a global ...
  • Sadkia C, Hachtb B, Soulimana A, Atmania F. 2010. Acute ...
  • Safarinejad MR. 2007. Adult urolithiasis in a population-based study in ...
  • Satoh KEI. 1978. Serum lipid peroxide in cerebrovascular diorders determined ...
  • Shabi MM, Gayathri K, Venkatalakshmi R, Sasikala C. 2010. Chemical ...
  • Shekha MS, Qadir AB, Ali HH, Selim XE.2014. Effect of ...
  • Sindhu G, Ratheesh M, Shyni GL, Helen A. 2009. Inhibitory ...
  • Stoller M, Bolton D. 2004. Smith’s general urology, 15th ed. ...
  • Watson JD. 2014. Type 2 diabetes as a redox disease. ...
  • Yadav RD, Jain SK, Alok S, Mahor A, Bharti JP, ...
  • نمایش کامل مراجع